论文信息 - Safety of FOLFIRI + Durvalumab +/− Tremelimumab in Second Line of Patients with Advanced Gastric Cancer: A Safety Run-In from the Randomized Phase II Study DURIGAST PRODIGE 59 - 字舞流文

Safety of FOLFIRI + Durvalumab +/− Tremelimumab in Second Line of Patients with Advanced Gastric Cancer: A Safety Run-In from the Randomized Phase II Study DURIGAST PRODIGE 59

C. Lepage | D. Botsen | O. Bouché | K. Le Malicot | D. Tougeron | T. Aparicio | J. Desramé | F. El Hajbi | C. Evrard | É. Soularue | D. Gonzalez | On Behalf Of The Durigast-Prodige Investigators/Co | F. El hajbi